Orphazyme orphazyme.com


Public lists: Pharma Startups (4733)

Orphazyme develops new therapies for the treatment of rare and genetic diseases. The company is founded on the pioneering research from the laboratory of Professor Marja Jaattela, and with the aim of converting human chaperone proteins into effective therapies for degenerative diseases. Orphazyme's novel technology also has the potential to address the neurodegenerative aspects of these devastating diseases. Orphazyme's core program is developing heat shock protein based therapies for the treatm...Show all

Orphazyme develops new therapies for the treatment of rare and genetic diseases. The company is founded on the pioneering research from the laboratory of Professor Marja Jaattela, and with the aim of converting human chaperone proteins into effective...Show all

Company (IPO / Went public)

Phone: (+45) 70 70 29 80

Fax:

Ole Maal√łes Vej 3

Copenhagen, DK-2200
Denmark

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Orphazyme $155.9M Nov 16, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Orphazyme Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Use of hsp70 as a regulator of enzymatic activity Feb 19, 2016 Feb 06, 2018 Patent
Methods for increasing intracellular activity of hsp70 Nov 22, 2011 May 30, 2017 Patent
Use of hsp70 as a regulator of enzymatic activity Aug 19, 2013 Mar 22, 2016 Patent
Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases Sep 12, 2011 Feb 24, 2015 Patent
Use of hsp70 as a regulator of enzymatic activity Jun 26, 2009 Sep 24, 2013 Patent
See all 9 patents